Literature DB >> 7176462

Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine.

W Kirch, H Spahn, H Köhler, E E Ohnhaus, E Mutschler.   

Abstract

Pharmacokinetics of metoprolol, propranolol, and atenolol were investigated in six healthy volunteers following 7 days of oral monotherapy with these drugs, and after 7 days concurrent administration of each of these betareceptor antagonists with cimetidine. Application of cimetidine did not lead to any interaction with atenolol, whereas mean peak plasma levels of metoprolol were increased by 70%, and those of propranolol by 95% due to concurrent administration of cimetidine (P less than 0.05). The plasma level time curve (AUC) of the two above-mentioned beta blockers behaved similarly (P less than 0.05). Other kinetic parameters of these two drugs were not influenced to a statistically significant extent by cimetidine, despite the tendency for the elimination half-life of metoprolol and propranolol to be prolonged when cimetidine is added. Measurement of exercise-induced tachycardia on the sixth day of administration showed no differences between monotherapy with the beta blockers and combined treatment with each of them together with cimetidine. Apart from one volunteer who complained of anxiety, weakness, and sweating on the sixth day of cimetidine/metoprolol administration, no adverse effects could be observed during the combination therapy with cimetidine and the beta blockers, nor during monotherapy with beta blockers.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7176462     DOI: 10.1007/bf01716245

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  17 in total

1.  Relationship between blood level of atenolol and pharmacologic effect.

Authors:  A Amery; J F De Plaen; P Lijnen; J McAinsh; T Reybrouck
Journal:  Clin Pharmacol Ther       Date:  1977-06       Impact factor: 6.875

2.  Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.

Authors:  G H Evans; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

3.  Cimetidine and bioavailability of propranolol.

Authors:  M A Donovan; A M Heagerty; L Patel; M Castleden; J E Pohl
Journal:  Lancet       Date:  1981-01-17       Impact factor: 79.321

4.  Fluorimetric determination of oxprenolol in plasma by direct evaluation of thin-layer chromatograms.

Authors:  M Schäfer; E Mutschler
Journal:  J Chromatogr       Date:  1979-10-11

5.  Influence of cimetidine on pharmacokinetics of propranolol.

Authors:  A M Heagerty; M A Donovan; C M Castleden; J F Pohl; L Patel; A Hedges
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-13

6.  Plasma levels and effects of metoprolol after single and multiple oral doses.

Authors:  P Collste; K Haglund; C von Bahr
Journal:  Clin Pharmacol Ther       Date:  1980-04       Impact factor: 6.875

7.  Kinetics and absolute bioavailability of atenolol.

Authors:  W D Mason; N Winer; G Kochak; I Cohen; R Bell
Journal:  Clin Pharmacol Ther       Date:  1979-04       Impact factor: 6.875

8.  Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.

Authors:  H C Brown; S G Carruthers; G D Johnston; J G Kelly; J McAinsh; D G McDevitt; R G Shanks
Journal:  Clin Pharmacol Ther       Date:  1976-11       Impact factor: 6.875

9.  Interaction of atenolol with furosemide and calcium and aluminum salts.

Authors:  W Kirch; M Schäfer-Korting; T Axthelm; H Köhler; E Mutschler
Journal:  Clin Pharmacol Ther       Date:  1981-10       Impact factor: 6.875

10.  [Fluorometric determination of propranolol and its metabolite n-desisopropylpropranolol in plasma and urine by direct meausrement of thin-layer chromatographic plates (author's transl].

Authors:  M Schäfer; H E Geissler; E Mutschler
Journal:  J Chromatogr       Date:  1977-11-01
View more
  14 in total

1.  Which concentration of the inhibitor should be used to predict in vivo drug interactions from in vitro data?

Authors:  Kiyomi Ito; Koji Chiba; Masato Horikawa; Michi Ishigami; Naomi Mizuno; Jun Aoki; Yasumasa Gotoh; Takafumi Iwatsubo; Shin-ichi Kanamitsu; Motohiro Kato; Iichiro Kawahara; Kayoko Niinuma; Akiko Nishino; Norihito Sato; Yuko Tsukamoto; Kaoru Ueda; Tomoo Itoh; Yuichi Sugiyama
Journal:  AAPS PharmSci       Date:  2002

Review 2.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

3.  H2 receptor antagonists: cimetidine and ranitidine.

Authors:  J R Wood
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-30

4.  Influence of ranitidine on plasma metoprolol and atenolol concentrations.

Authors:  H Spahn; E Mutschler; W Kirch; E E Ohnhaus; H D Janisch
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-14

5.  Kinetic interactions of nadolol and propranolol with cimetidine.

Authors:  K L Duchin; M A Stern; D A Willard; D N McKinstry
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

Review 6.  Drug interactions between prescribed and over-the-counter medication.

Authors:  P K Honig; B K Gillespie
Journal:  Drug Saf       Date:  1995-11       Impact factor: 5.606

7.  Impact of Substrate-Dependent Inhibition on Renal Organic Cation Transporters hOCT2 and hMATE1/2-K-Mediated Drug Transport and Intracellular Accumulation.

Authors:  Jia Yin; Haichuan Duan; Joanne Wang
Journal:  J Pharmacol Exp Ther       Date:  2016-10-06       Impact factor: 4.030

8.  Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.

Authors:  D Gangji; M Juvent; G Niset; M Wathieu; M Degreve; R Bellens; J Poortmans; S Degre; T J Fitzsimons; A Herchuelz
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

9.  The interaction between H2-receptor antagonists and beta-adrenoceptor blockers.

Authors:  E Mutschler; H Spahn; W Kirch
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

Review 10.  Pharmacokinetic interactions of cimetidine 1987.

Authors:  A Somogyi; M Muirhead
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.